Background & Key Objectives:
Te purpose of this research is to understand current IBD treatment practices and opportunities for new biologics/advanced treatments for this therapy area. The focus of this survey is ulcerative colitis (UC) however and Crohn’s disease (CD) management. Client wanted to know what ‘advanced therapies’ to describe all classes of advanced treatments (eg. biologics, biosimilars of biologics and JAK inhibitors) used by the managment of their IBD treatment.
Research Audience & Samples:
Gastroenterologist and IBD Specialist. We covered 65 samples from Indian market.
LOI : 40 Minutes
Method: Online
